Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of NMIBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment OF NON-MUSCLE Invasive Bladder Cancer
J Urol 2022 Jul 05;[EPub Ahead of Print], IM McElree, VT Packiam, RL Steinberg, SL Mott, PT Gellhaus, KG Nepple, MA O'DonnellFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.